In conclusion, humanized homozygous mutant CYP21A2 mice not only serve as a robust model for studying the 21-hydroxylase function and the metabolic aspects of CAH, but they also represent a valuable model for clinical applications such as the testing of novel therapies in the future. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.